title: Use of landiolol in the perioperative management of supraventricular tachycardia.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Ito
authors.forename: Kazuya
authors.initials: K
authors.lastname: Sobue
authors.forename: Minhye
authors.initials: M
authors.lastname: So
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Hirate
authors.forename: Takeshi
authors.initials: T
authors.lastname: Sugiura
authors.forename: Takafumi
authors.initials: T
authors.lastname: Azami
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Sasano
authors.forename: Hirotada
authors.initials: H
authors.lastname: Katsuya
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects; D002315:Cardiopulmonary Bypass; D002316:Cardiotonic Agents / Q000008:administration & dosage; D004298:Dopamine / Q000008:administration & dosage; D004437:Ebstein Anomaly / Q000601:surgery; D004554:Electric Countershock / Q000379:methods; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000188:drug therapy / Q000209:etiology; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D019990:Perioperative Care / Q000379:methods*; D011183:Postoperative Complications / Q000188:drug therapy; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*; D016896:Treatment Outcome; D014508:Urea / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D009025:Morpholines; C077049:landiolol; D014508:Urea; D004298:Dopamine